Sputum proteomics in lung disorders

Area of Science:

• Pulmonary Medicine
• Proteomics
• Biochemistry

Background:

• Lung diseases impair respiratory function due to infections and environmental factors, often leading to diagnostic challenges due to overlapping symptoms.
• Early identification of inflammatory markers is crucial for understanding disease mechanisms and improving diagnosis and treatment of pulmonary conditions.
• Sputum proteomics is a valuable tool for investigating the genetic and environmental factors contributing to lung disease development and progression.

Purpose of the Study:

• To explore the potential of sputum proteomics for early diagnosis and understanding of lung diseases.
• To provide a comprehensive overview of sputum collection, processing, and analysis techniques for proteomic studies.
• To review the application of sputum proteomics in severe lung disorders like COVID-19, COPD, asthma, cystic fibrosis, lung cancer, and tuberculosis.

Main Methods:

• Review of existing literature on lung diseases, sputum analysis, proteomics, and mass spectrometry.
• Description of proteomic techniques and analytical approaches for investigating the sputum proteome.
• Case study analysis of sputum proteomics applications in various severe lung diseases.

Main Results:

• Sputum is a rich source of proteins, making it suitable for proteomic analysis.
• Proteomic analysis of sputum can reveal specific markers of inflammation and disease.
• Challenges in sputum analysis include interfering factors that require careful consideration during processing and interpretation.

Conclusions:

• Sputum proteomics holds significant potential for the early diagnosis and personalized treatment of diverse lung diseases.
• Further research and standardization of methods are needed to fully leverage sputum proteomics in clinical practice.
• This approach can enhance our understanding of the molecular underpinnings of lung pathologies, paving the way for novel therapeutic strategies.